Explanation of clinical, bioanalytical and statistical contents of report in relation to the pharmacological interpretation of the results obtained. Writing and/or reviewing final study reports to ensure they reflect the study results obtained for use to submit to regulatory bodies such as TPD,FDA, EU and other regulatory agencies.
Too often, different sections of reports are written in isolation. HT Pharmaceuticals has the experience of correlating all sections to ensure the report flows cohesively and is comprehensive. Having the expertise in study designs, HT Pharmaceutical will provide a review or write up of the report to ensure the objectives set in the protocol are reflected in the final result interpretation.